Kasvu Therapeutics

Kasvu Therapeutics is a drug development company focused on creating non-hallucinogenic small molecules to treat neuropsychiatric and neurodegenerative disorders, leveraging neuroplasticity to improve brain function

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical development

Model

01Company Overview

02Backed By2 investors

HVHadean Ventures→NSNordic Science Investments→

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

Recent Activity

FROM Nordic Science Investments

Continued participation in Kasvu Therapeutics' €30M Series A round led by Hadean Ventures for its neuroplasticity-based depression treatment.

INVESTMENT·nordscience.fi+1

SEP 24, 2026

FROM Hadean Ventures

Led Kasvu Therapeutics' EUR 30M Series A to advance its TrkB potentiator into clinical development for neuropsychiatric disorders.

INVESTMENT·hadeanventures.com+1

SEP 24, 2026

04Similar Companies

T

Tenvie

Biotech & Life Sciences

→

NT

Neurofold Therapeutics

Biotech & Life Sciences

→

A

Axonis

Biotech & Life Sciences

→

LT

Leal Therapeutics

Biotech & Life Sciences

→

X

Xylo

Biotech & Life Sciences

→

05Startup DNA

signals

Sectors
Business Model
Technology

Quick Reference

Sector

Biotech & Life Sciences · Healthcare & Digital Health